• Bed capacity expansion: Operational capacity is set to increase from 4,290 beds to 5,040 beds in FY27, 6,040 beds in FY28, and approximately 6,600 beds by November 2028 through multiple greenfield, brownfield, and PPP projects.
• Occupancy and ALOS: Blended occupancy is expected to remain between 57% and 60% over the next two financial years due to ongoing capacity additions, while average length of stay is targeted to decline from 5.94 to 5.5 days over the next 6 to 9 months.
• Revenue growth outlook: Management expects a 10-year revenue CAGR of 22% to 24%, projecting top-line operational income of roughly ₹2,100 crore in FY27 and ₹2,600 crore in FY28.
• ARPOB and patient mix: ARPOB is guided to grow at 10% to 12% annually from ₹30,444 in Q1 FY27, with the cash/TPA to government scheme revenue mix expected to shift from 25:75 to 30:70 over the next 12 to 18 months.
• Receivable cycle improvement: Working capital days have compressed from 160+ to 125–130 days as of Q1 FY27, with management guiding for a further reduction to 100–110 days within the next 12 months.